WHO adds two candidate vaccines to Ebola trial in DR Congo
The WHO included ChAdOx1 BDBV and mRNA-1469 vaccines in clinical trials in the Democratic Republic of Congo following a Bundibugyo Ebola outbreak.
The WHO included ChAdOx1 BDBV and mRNA-1469 vaccines in clinical trials in the Democratic Republic of Congo following a Bundibugyo Ebola outbreak.